Results 61 to 70 of about 18,839 (215)

Optimal management of pernicious anemia

open access: yesJournal of Blood Medicine, 2012
Emmanuel Andres,1,2 Khalid Serraj31Department of Internal Medicine, Diabetes, and Metabolic Disorders, 2Competence Center of Autoimmune Cytopenias in Adults, University Hospital of Strasbourg, Strasbourg, France; 3Department of Internal Medicine ...
Serraj K, Andres E
doaj  

Significantly higher frequencies of anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody positivity in atrophic glossitis patients

open access: yesJournal of the Formosan Medical Association, 2018
Background/Purpose: Atrophic glossitis (AG) patients are prone to have anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody (GPCA) positivity.
Chun-Pin Chiang   +5 more
doaj   +1 more source

Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in atrophic glossitis patients with iron deficiency

open access: yesJournal of the Formosan Medical Association, 2020
Background/Purpose: Our previous study found that 180 of 1064 atrophic glossitis (AG) patients have iron deficiency. This study assessed whether all AG patients with iron deficiency (so-called ID/AG patients) had iron deficiency anemia (IDA) and ...
Chun-Pin Chiang   +5 more
doaj   +1 more source

A Difficult‐to‐Manage Case of Primary Idiopathic Erythromelalgia—Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Erythromelalgia is a rare condition with symptoms of erythema, warmth, and painful extremities exacerbated by warmth and relieved by cooling. Pain management is often challenging. The sodium channel blocker, lacosamide, was most effective in this patient.
Sarah Wide   +3 more
wiley   +1 more source

Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia

open access: yesCase Reports in Hematology, 2017
Introduction. Acquired thrombotic thrombocytopenic purpura (TTP) has been associated with different autoimmune disorders. However, its association with pernicious anemia is rarely reported. Case Report.
Ramesh Kumar Pandey   +4 more
doaj   +1 more source

Anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody positivity in 884 patients with burning mouth syndrome

open access: yesJournal of the Formosan Medical Association, 2020
Background/Purpose: Burning mouth syndrome (BMS) is characterized by burning sensation of the oral mucosa in the absence of clinically apparent oral mucosal alterations.
Chun-Pin Chiang   +5 more
doaj   +1 more source

Anemia, hematinic deficiencies, and gastric parietal cell antibody positivity in atrophic glossitis patients with or without hyperhomocysteinemia

open access: yesJournal of the Formosan Medical Association, 2020
Background/Purpose: Our previous study found that 127 of 1064 atrophic glossitis (AG) patients have hyperhomocysteinemia. This study assessed whether the AG patients with hyperhomocysteinemia had significantly higher frequencies of anemia, hematinic ...
Chun-Pin Chiang   +5 more
doaj   +1 more source

From Immunization to Autoimmunity: A Deep Dive Into Post‐COVID‐19 Vaccine Reactions—A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Coronavirus disease‐2019 (COVID‐19) emerged in 2019 from Wuhan, China, leading to the accelerated development of vaccines, which have proven instrumental in controlling the spread of the virus. While vaccination ceased the increasing trend of the viral infection, rare adverse autoimmune events emerged as important ...
Mohammad Javad Yousefi‐Hashemabad   +6 more
wiley   +1 more source

Pseudo-thrombotic thrombocytopenic purpura presenting as multi-organ dysfunction syndrome: A rare complication of pernicious anemia

open access: yesSAGE Open Medical Case Reports, 2017
Objective: We present a rare case of pernicious anemia presented as multi-organ dysfunction syndrome, later found to have pseudo-thrombotic thrombocytopenic purpura.
Saroj Kandel   +9 more
doaj   +1 more source

Care Pathways and Determinants in Essure® Contraceptive Implant Use and Removal: A Qualitative Study

open access: yesHealth Expectations, Volume 29, Issue 2, April 2026.
ABSTRACT Background Introduced in 2002, the Essure® implant was promoted as a minimally invasive permanent contraceptive. After widespread use, increasing reports of adverse effects led to its global withdrawal in 2018. This study explores the experiences of women in France who chose Essure®, focusing on their motivations and the factors leading to its
Jéronine Tengue   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy